AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZD2624 Multiple Ascending Dose Study in Japan
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2009-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00696865
- Locations
- 🇯🇵
Research Site, Kanagawa, Japan
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
Completed
- Conditions
- GERD
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 5084
- Registration Number
- NCT00695838
- Locations
- 🇫🇷
Research Site, Yvre L Eveque, France
National Survey on Infiltrative Breast Cancer
Completed
- Conditions
- Infiltrative Breast Cancer
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1500
- Registration Number
- NCT00696527
- Locations
- 🇫🇷
Research Site, Villejuif Cedex, France
National Survey on Hypertension in General Practitioner (GP) Consultation
Completed
- Conditions
- Hypertension
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2853
- Registration Number
- NCT00695656
- Locations
- 🇫🇷
Research Site, Zuydcoote, France
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
Completed
- Conditions
- Hypercholesterolaemia
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-10-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 810
- Registration Number
- NCT00695539
- Locations
- 🇬🇷
Research Site, Thessaloniki, Greece
Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Completed
- Conditions
- New StrategiesGINA 2006Patient Opinion
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2009-04-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 832
- Registration Number
- NCT00695357
- Locations
- 🇬🇷
Research Site, Xalkida, Greece
National Survey on Hypertension at Hospital
Completed
- Conditions
- Hypertension
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 655
- Registration Number
- NCT00695266
- Locations
- 🇫🇷
Research Site, Villeneuve St Georges Cedex, France
National Survey on Hypertension in Cardiologic Private Practice
Completed
- Conditions
- Hypertension
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1800
- Registration Number
- NCT00695175
- Locations
- 🇫🇷
Research Site, Yvetot, France
Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)
Phase 1
Completed
- Conditions
- Capsaicin Evoked PainHeat Sensitivity
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2008-06-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT00692146
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid
Phase 1
Completed
- Conditions
- Alzheimer´s Disease
- Interventions
- Drug: Radioligand (11C)AZD2995Drug: Radioligand (11C)AZD2184
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2009-01-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 13
- Registration Number
- NCT00692705
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath